Literature DB >> 8387064

Good performance status of long-term disease-free survivors of intracranial gliomas.

L Kleinberg1, K Wallner, M G Malkin.   

Abstract

PURPOSE: To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function were used to evaluate the status of adults who are alive and disease-free more than 1 year after cranial irradiation. METHODS AND MATERIALS: Of 30 eligible adult patients, seventeen patients had anaplastic astrocytoma, seven had a glioblastoma, four had low grade astrocytoma, one had a mixed glioma, and one had an anaplastic oligodendroglioma. Sixteen patients received partial brain irradiation only, 12 had whole brain irradiation with a partial brain boost, and two had whole brain irradiation only. The total dose ranged from 54-66 Gy, with a fraction size of 1.7-2.0 Gy. Median follow-up was 3.5 years. Eighty-three percent of patients also received adjuvant chemotherapy.
RESULTS: Karnofsky Performance Status generally remained stable after the completion of irradiation. Mean Performance status was 84 at the end of irradiation and was unchanged at the time of last follow-up. The actuarial freedom from performance status decline after irradiation was 93% at 5 years. The performance status increased in two patients, both within several months of completing irradiation. Most patients (68%) returned to work after irradiation. Sixty-two percent remained at work 1 year later, and 58% were working at the time of last follow-up. No patient who did not return to work within 4 months of completing irradiation was able to work at a later date. All working patients were employed in a capacity similar to their pre-morbid position. Only one patient, with an intercurrent lung cancer, eventually developed deficits that limited self care.
CONCLUSIONS: Contrary to previously published reports, long-term glioma survivors maintained a relatively good performance status in the absence of recurrence and did not experience a progressive decline in neuropsychologic function after completion of cranial irradiation. A patient's function state at the completion of irradiation is a reliable predictor of long-term functional outcome in the absence of recurrence. Although the number of patients in each subgroup is small and no significant differences could be detected, patients treated with partial brain irradiation had a higher and more stable performance status, better memory function, and superior employment history.

Entities:  

Mesh:

Year:  1993        PMID: 8387064     DOI: 10.1016/0360-3016(93)90183-v

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour.

Authors:  A R Giovagnoli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  Radiation dose-volume effects in the brain.

Authors:  Yaacov Richard Lawrence; X Allen Li; Issam el Naqa; Carol A Hahn; Lawrence B Marks; Thomas E Merchant; Adam P Dicker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 3.  Investigation of cognitive impairments in people with brain tumors.

Authors:  Anna Rita Giovagnoli
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

4.  Long-term memory deficits in patients with malignant gliomas.

Authors:  P Salander; T Karlsson; T Bergenheim; R Henriksson
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 5.  Neurologic sequelae of treatment of primary CNS lymphomas.

Authors:  U Schlegel; H Pels; R Oehring; I Blümcke
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 6.  Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual disease.

Authors:  Shannon E Fogh; Lauren Boreta; Jean L Nakamura; Derek R Johnson; Andrew S Chi; Sylvia C Kurz
Journal:  Neurooncol Pract       Date:  2020-06-27

7.  Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Authors:  Cecelia Gzell; H Wheeler; L Guo; M Kastelan; M Back
Journal:  J Cancer Surviv       Date:  2013-11-09       Impact factor: 4.442

8.  Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma.

Authors:  M H J Swennen; J E C Bromberg; Th D Witkamp; C H J Terhaard; T J Postma; M J B Taphoorn
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

Review 9.  Current management of choroid plexus carcinomas.

Authors:  Matthew Z Sun; Michael C Oh; Michael E Ivan; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Joanna J Phillips; Kurtis I Auguste; Andrew T Parsa
Journal:  Neurosurg Rev       Date:  2013-09-26       Impact factor: 3.042

10.  Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma.

Authors:  Feyzi Birol Sarica; Melih Cekinmez; Kadir Tufan; Orhan Sen; Huseyin C Onal; Huseyin Mertsoylu; Erkan Topkan; Berrin Pehlivan; Bulent Erdogan; Mehmet N Altinors
Journal:  Asian J Neurosurg       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.